25.07.2021 Views

Microbiology, 2021

Microbiology, 2021

Microbiology, 2021

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

574 14 • Antimicrobial Drugs<br />

Drugs That Inhibit Bacterial Protein Synthesis<br />

Molecular<br />

Target<br />

Mechanism of Action Drug Class Specific Drugs<br />

Bacteriostatic<br />

or<br />

Bactericidal<br />

Spectrum<br />

of<br />

Activity<br />

30S<br />

subunit<br />

Causes mismatches<br />

between codons and<br />

anticodons, leading to<br />

faulty proteins that<br />

insert into and disrupt<br />

cytoplasmic membrane<br />

Aminoglycosides<br />

Streptomycin,<br />

gentamicin,<br />

neomycin,<br />

kanamycin<br />

Bactericidal<br />

Broad<br />

spectrum<br />

Blocks association of<br />

tRNAs with ribosome<br />

Tetracyclines<br />

Tetracycline,<br />

doxycycline,<br />

tigecycline<br />

Bacteriostatic<br />

Broad<br />

spectrum<br />

Blocks peptide bond<br />

formation between<br />

amino acids<br />

Macrolides<br />

Lincosamides<br />

Erythromycin,<br />

azithromycin,<br />

telithromycin<br />

Lincomycin,<br />

clindamycin<br />

Bacteriostatic<br />

Bacteriostatic<br />

Broad<br />

spectrum<br />

Narrow<br />

spectrum<br />

50S<br />

subunit<br />

Not applicable Chloramphenicol Bacteriostatic<br />

Broad<br />

spectrum<br />

Interferes with the<br />

formation of the<br />

initiation complex<br />

between 50S and 30S<br />

subunits and other<br />

factors.<br />

Oxazolidinones Linezolid Bacteriostatic<br />

Broad<br />

spectrum<br />

Table 14.3<br />

CHECK YOUR UNDERSTANDING<br />

• Compare and contrast the different types of protein synthesis inhibitors.<br />

Inhibitors of Membrane Function<br />

A small group of antibacterials target the bacterial membrane as their mode of action (Table 14.4). The<br />

polymyxins are natural polypeptide antibiotics that were first discovered in 1947 as products of Bacillus<br />

polymyxa; only polymyxin B and polymyxin E (colistin) have been used clinically. They are lipophilic with<br />

detergent-like properties and interact with the lipopolysaccharide component of the outer membrane of gramnegative<br />

bacteria, ultimately disrupting both their outer and inner membranes and killing the bacterial cells.<br />

Unfortunately, the membrane-targeting mechanism is not a selective toxicity, and these drugs also target and<br />

damage the membrane of cells in the kidney and nervous system when administered systemically. Because of<br />

these serious side effects and their poor absorption from the digestive tract, polymyxin B is used in over-thecounter<br />

topical antibiotic ointments (e.g., Neosporin), and oral colistin was historically used only for bowel<br />

decontamination to prevent infections originating from bowel microbes in immunocompromised patients or<br />

for those undergoing certain abdominal surgeries. However, the emergence and spread of multidrug-resistant<br />

Access for free at openstax.org.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!